Skip to Main Content

Paper Details

MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.
Mol Oncol
2
2022
-inactivated BTCs, BTC, BTCs, Biliary tract cancers, Cancer, MGMT, MGMT mRNA, MGMT promoter, MGMT protein, MGMT-inactivated BTCs, O -methylguanine, O -methylguanine-DNA methyltransferase, RNA, Tumor Diseases, advanced BTC, advanced biliary tract cancers, patients
Author NameAffiliation
Daniel H??bschmannNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Daniel H??bschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine
Daniel H??bschmann
Daniel H??bschmannNational Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Daniel H??bschmann
Daniel H??bschmannHeidelberg Institute for Stem Cell Technology and Experimental Medicine
Stefan Fr??hling
Stefan Fr??hlingGerman Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT) Heidelberg
  • 1 - 8

Datasets

Release 1.2